نتائج البحث

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study.

• Authors : Eliasson B; Department of Molecular and Clinical Medicine, University of Gothenburg, Göteborg, Sweden. ; Möller-Goede D

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use

• Source: Diabetologia [Diabetologia] 2012 Apr; Vol. 55 (4), pp. 915-25. Date of Electronic Publication: 2012 Jan 12.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان